|
Official Course
Description: MCCCD Approval: 12-11-2007 |
|||||
|
NCE101 2011 Fall – 2012 Fall |
LEC 2.0 Credit(s) 2.0 Period(s) 2.0 Load Occ |
||||
|
Introduction
and Overview of Cancer Disease |
|||||
|
Introduction and overview of the disease and treatment of
cancer including cancer origin, development, pathology, staging,
hematopoiesis, epidemiology, diagnosis modalities, treatment options, cancer
research and differentiation of solid tumors versus nonsolid tumors.
Effective analysis, synthesis, and evaluation of topics through written
discourse. Prerequisites: Health care professional,
or permission of Department or Division. |
|||||
|
Cross-References:
CRC101 |
|||||
Go to Competencies Go to Outline
|
MCCCD
Official Course Competencies: |
|
|
|
|
|
NCE101 2011 Fall
– 2012 Fall |
Introduction and Overview of Cancer Disease |
|
1.
|
Describe cancer's origin and development. (I) |
|
2.
|
Contrast and differentiate staging versus grading in
cancer. (I) |
|
3.
|
Describe the role of the tumor registrar and the pathologist.
(I) |
|
4.
|
Discuss the epidemiology, diagnosis, staging and treatment
of specific cancers. (II) |
|
5.
|
Describe the process of hematopoiesis by listing the
progenitor cells and their offspring. (III) |
|
6.
|
Define the difference between humoral
and cell-mediated immunity. (III) |
|
7.
|
Compare acute and chronic types of leukemia. (III) |
|
8.
|
Compare Hodgkin's Lymphoma with Non-Hodgkin's Lymphoma.
(III) |
|
9.
|
Describe the stages and drug development process of cancer
research. (IV) |
|
10.
|
Describe three structural and three metabolic emergencies
in oncology and their treatment options. (V) |
Go to Description Go to top of
Competencies
|
MCCCD
Official Course Outline: |
|
|
|
|
|
NCE101 2011
Fall – 2102 Fall |
Introduction and Overview of Cancer Disease |
|
I. Basics of
Oncology/Cancer A. Cancer epidemiology and
characteristics B. Types of staging and
techniques C. Detection/diagnostic
methods D. Treatment options II. Types of Cancer A. Lung B. Breast C. Colon D. Prostate E. Gynecologic F. Head and Neck G. Testicular III. Hematopoiesis A. Normal Hematopoiesis B. Normal Immune system C. Hematologic Malignancies
IV. Cancer Research A. National Institutes of
Health/National Cancer Institute/Cooperative Group Trials B. Basic, Translational and
Clinical Research C. Drug, Biologic, Device
Research V. Oncologic Emergencies A. Superior Vena Cava
Syndrome (SVC) Syndrome B. Tumor Lysis Syndrome C. Spinal Cord Compression D. Syndrome of
Inappropriate Antidiuretic Hormone Secretion (SIADH) E. Sepsis F. Hypercalcemia
|
Go to Description Go to top of
Competencies Go to top of Outline